Depramine
Depramine is a tricyclic antidepressant (TCA) that is used primarily in the treatment of major depressive disorder. It is known for its efficacy in alleviating symptoms of depression by influencing the levels of certain chemicals in the brain, particularly norepinephrine and serotonin.
Mechanism of Action
Depramine works by inhibiting the reuptake of norepinephrine and serotonin, two neurotransmitters that are believed to play a crucial role in mood regulation. By preventing the reabsorption of these neurotransmitters, Depramine increases their levels in the synaptic cleft, thereby enhancing neurotransmission and improving mood.
Indications
Depramine is primarily indicated for the treatment of major depressive disorder. It may also be used off-label for other conditions such as anxiety disorders, chronic pain, and obsessive-compulsive disorder (OCD).
Side Effects
Common side effects of Depramine include:
Serious side effects may include:
- Cardiac arrhythmias
- Seizures
- Orthostatic hypotension
- Mania in patients with bipolar disorder
Contraindications
Depramine is contraindicated in patients with:
- Hypersensitivity to tricyclic antidepressants
- Recent myocardial infarction
- Severe liver disease
- Concurrent use of monoamine oxidase inhibitors (MAOIs)
Drug Interactions
Depramine can interact with several other medications, including:
- Monoamine oxidase inhibitors (MAOIs)
- Selective serotonin reuptake inhibitors (SSRIs)
- Anticholinergic agents
- Sympathomimetic drugs
Dosage and Administration
The dosage of Depramine varies depending on the severity of the condition being treated and the patient's response to the medication. It is typically started at a low dose and gradually increased. The medication is usually taken orally, with or without food.
Monitoring
Patients on Depramine should be regularly monitored for:
Discontinuation
Abrupt discontinuation of Depramine can lead to withdrawal symptoms such as:
It is recommended to taper the dose gradually under medical supervision.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD